In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

NeoGenomics buys Genoptix for $125mm cash plus stock

Executive Summary

NeoGenomics Inc. signed a definitive agreement to acquire clinical cancer lab services firm Genoptix Inc. for $125mm in cash plus 1mm NeoGenomics shares (valued at $13.9mm based on the market average ten days prior to the announcement of the deal).
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Payment Includes Cash
    • Full Acquisition
    • Intra-Biotech Deal
    • Payment Includes Stock

Related Companies

Advertisement
UsernamePublicRestriction

Register